mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination

Autor:	Jacqueline K. Shaia, Priya Shukla, Lee Jampol, Rishi P. Singh
Jazyk:	angličtina
Rok vydání:	2024
Předmět:	Immunologic diseases. Allergy RC581-607 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	npj Vaccines, Vol 9, Iss 1, Pp 1-2 (2024)
Druh dokumentu:	article
ISSN:	2059-0105
DOI:	10.1038/s41541-024-00983-0
Popis:	Abstract Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to increase the risk of RVOs at 3 and 12 weeks post-vaccination. Although both studies had different designs, mRNA vaccines do not appear to influence the risk of RVO development.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/5fb58b39a96942488d07810f1a3edd8c Zobrazit plný text záznamu Full text from SpringerLink View record in DOAJ